Cerebral venous thrombosis associated with COVID-19

Close metadata

Recommended articles:

A clinical case of the new-onset bipolar affective disorder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129

Causes of hospital mortality in adults based on medical certificates of death. Russian Journal of Preventive Medicine. 2024;(3):7-13

Antibiotic resistance of the upper respiratory tract microbiota in children with the new coronavirus infection in Ryazan. Russian Journal of Preventive Medicine. 2024;(3):45-51

Adverse perinatal outcomes in COVID-19. Analysis of a series of clinical observations. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):86-90

Staging of COVID-19 morphological manifestations in lungs depending on disease duration. Forensic Medical Expertise. 2024;(2):28-31

Russian COVID-19 vaccines as a risk factor of myopericarditis in patients with or without previous infection. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(2):184-193

Exosomes’ role in intercellular interactions in different variants of lung injury in fatal cases of COVID-19. Russian Journal of Archive of Pathology. 2024;(2):22-29

Variability of death rates from respiratory diseases in the regions of the Russian Federation during the COVID-19 pandemic and the three previous years. Russian Journal of Preventive Medicine. 2024;(4):82-88

Efficacy and safety of a new selective oral factor Xa inhibitor amidine hydrochloride for the prevention of thromboembolic events in hospitalized patients with COVID-19. Results of a multicenter, prospective, randomized, controlled study. Journal of Venous Disorders. 2024;(2):154-162

Structural-functional status of cardiovascular and respiratory systems, psychoemotional disorders in patients with COVID-19 at the time of hospital discharge. Russian Journal of Preventive Medicine. 2024;(5):60-68

The literature reports that cerebral venous thrombosis (CVT) develops in 1—1.5% of patients with COVID-19. Recently, a new syndrome named vaccine-induced immune thrombotic thrombocytopenia (VITT) has been described. VITT is a rare side-effect of COVID-19 vaccination that also causes CVT. The article presents an overview of the above problem and a clinical case of a patient with CVT that developed within a month after the first component of the Sputnik V vaccination and COVID-19.

Keywords:

COVID-19

vaccine-induced immune thrombotic thrombocytopenia

cerebral venous thrombosis

Authors:

Safina D.R.

Kazan Federal University

Gismatullina E.I.

Kazan (Volga region) Federal University

ORCID: 0000-0001-7575-354X

Esin R.G.

Kazan State Medical Academy — Branch of the Russian Medical Academy of Continuing Professional Education;
Kazan (Volga Region) Federal University

ORCID: 0000-0001-6762-8845

Received:

27.03.2022

Accepted:

29.03.2022

List of references:

«COVID-19 Map.». Johns Hopkins Coronavirus Resource Center. Johns Hopkins Centers for Civic Impact; 2020. coronavirus.jhu.edu/map.html
Abdalkader M, Shaikh SP, Siegler JE, et al. Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature. J Stroke Cerebrovasc Dis. 2021;30(6):105733. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105733
Al-Mufti F, Amuluru K, Sahni R, et al. Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study. AJNR Am J Neuroradiol. 2021;42(7):1196-1200. https://doi.org/10.3174/ajnr.A7134
Wang HY, Li XL, Yan ZR, et al. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord. 2020;13:1756286420917830. https://doi.org/10.1177/1756286420917830
Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. https://doi.org/10.1001/jamaneurol.2020.1127
Siegler JE, Cardona P, Arenillas JF, et al. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry. Int J Stroke. 2021;16(4):437-447. https://doi.org/10.1177/1747493020959216
Nogueira RG, Abdalkader M, Qureshi MM, et al. Global impact of COVID-19 on stroke care. Int J Stroke. 2021;16(5):573-584. https://doi.org/10.1177/1747493021991652
Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352(17):1791-1798. https://doi.org/10.1056/NEJMra042354
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-2040. https://doi.org/10.1182/blood.2020006000
Tu TM, Goh C, Tan YK, et al. Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review. J Stroke Cerebrovasc Dis. 2020;29(12):105379. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105379
Baud D, Qi X, Nielsen-Saines K, et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773. https://doi.org/10.1016/S1473-3099(20)30195-X
Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6(2):162-170. https://doi.org/10.1016/S1474-4422(07)70029-7
Ortega-Gutierrez S, Holcombe A, Aksan N, et al. Association of admission clinical predictors and functional outcome in patients with Cerebral Venous and Dural Sinus Thrombosis. Clin Neurol Neurosurg. 2020;188:105563. https://doi.org/10.1016/j.clineuro.2019.105563
Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-670. https://doi.org/10.1161/01.STR.0000117571.76197.26
Mowla A, Shakibajahromi B, Shahjouei S, et al. Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series. J Neurol Sci. 2020;419:117183. https://doi.org/10.1016/j.jns.2020.117183
Dakay K, Cooper J, Bloomﬁeld J, et al. Cerebral Venous Sinus Thrombosis in COVID-19 infection: a case series and review of the literature. J Stroke Cerebrovasc Dis. 2021;30(1):105434. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105434
Cavalcanti DD, Raz E, Shapiro M, et al. Cerebral Venous Thrombosis Associated with COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1370-1376. https://doi.org/10.3174/ajnr.A6644
Hameed S, Wasay M, Soomro B.A, et al. Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study. Cerebrovasc Dis Extra. 2021;11(2):55-60. https://doi.org/10.1159/000516641
Perry RJ, Tamborska A, Singh B, et al. CVT After Immunisation Against COVID-19 (CAIAC) collaborators. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet. 2021;398(10306):1147-1156. https://doi.org/10.1016/S0140-6736(21)01608-1
https://congress-med.ru/assets/files/2021/2021-rukovodstvo-isth-po-vyiyavleniyu-i-lecheniyu-trombozov-posle-vakczinaczii-ot-covid.pdf and-treatment-of-thrombosis-after-vaccination-from-covid.pdf
Ferro JM, Coutinho JM, Dentali F, et al. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA Neurol. 2019;76(12):1457-1465. https://doi.org/10.1001/jamaneurol.2019.2764

Close metadata